DMCC Speciality Chemicals Ltd
DMCC Speciality Chemicals Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
0 of 2 strong
The short version
The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance. The management, represented by Bimal Goculdas, refrains from giving futuristic projections, maintaining focus on past and present performance.
From DMCC Speciality Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance.
- Specialty chemicals are expected to grow, with commercialization underway for new products (e.g., polymer used in enhanced oil recovery), but exact sales or margin projections are not provided.
- FY27 specialty chemical capacity utilization is expected to be better than FY25-26, though market conditions remain volatile.
- Growth in specialty chemicals aims to increase the portfolio to at least 50% of business to be considered a true specialty chemical company.
2 more points from DMCC Speciality Chemicals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what DMCC Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company received land near Ambernath (Nalimbi), currently under government custody due to pending registry; monetization plans are under consideration.
- Proceeds from monetizing this land, once realized, could be used for CAPEX or debt reduction.
- No specific timeline given for land registry transfer or monetization.
- No definitive projections or details about upcoming capital expenditure on new plants or expansions were shared.
- Focus remains on R&D with plans to increase intensity, supporting specialty chemical development.
2 more points from DMCC Speciality Chemicals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what DMCC Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- No specific details on current or expected order book or pending orders were provided during the conference call.
- Bimal Goculdas mentioned ongoing commercial sales in specialty boron products but did not give projections on volumes or margins.
- Discussions on specialty chemicals indicate progress towards commercial stages, but exact order quantities remain uncertain.
- The supply situation for sulfur and related chemicals is dynamic, affecting production but no direct information on order backlog.
2 more points from DMCC Speciality Chemicals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
DMCC Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹178 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What DMCC Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY22 earnings call analysis →
- Q1 FY24 earnings call analysis →
- Q1 FY23 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
- Rajputana Bio. (Q4 FY26)
Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against
- Neochem Bio (Q4 FY26)
Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…
Arthneeti Pro · Annual
DMCC Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were DMCC Speciality Chemicals Ltd Q4 FY26 results?
The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance. The management, represented by Bimal Goculdas, refrains from giving futuristic projections, maintaining focus on past and present performance.
What is DMCC Speciality Chemicals Ltd share price analysis?
DMCC Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 26.0 with a market cap of ₹710 Cr. Investors should review the full earnings analysis for detailed insights.
Is DMCC Speciality Chemicals Ltd planning capital expenditure?
The company received land near Ambernath (Nalimbi), currently under government custody due to pending registry; monetization plans are under consideration.
Keep DMCC Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.